Glucose transporters GLUT1 and GLUT2 are regulated at the transcriptional level by the AR [15–17], whereas control by AR-independent factors such as SOX2 and MYC promotes prostate cancer progression, lineage plasticity, and therapy resistance [18, 19]. This evidence concerns the gene AR and prostate carcinoma.